Cas:176526-00-4 2-pyridin-4-ylbenzaldehyde manufacturer & supplier

We serve Chemical Name:2-pyridin-4-ylbenzaldehyde CAS:176526-00-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-pyridin-4-ylbenzaldehyde

Chemical Name:2-pyridin-4-ylbenzaldehyde
CAS.NO:176526-00-4
Synonyms:Benzaldehyde, 2-(4-pyridinyl)-;2-(pyridin-4-yl)benzaldehyde;2-pyrid-4-ylbenzaldehyde;2-pyridin-4-ylbenzaldehyde;2-(4-Pyridyl)benzaldehyde;MFCD02684098;2-pyridin-4-yl-benzaldehyde;2-(4-Pyridinyl)benzaldehyde
Molecular Formula:C12H9NO
Molecular Weight:183.206
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:342.8±25.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.615
PSA:29.96000
Exact Mass:183.068420
LogP:1.71

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzaldehyde, 2-(4-pyridinyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-Pyridinyl)benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-pyridin-4-ylbenzaldehyde Use and application,2-pyridin-4-ylbenzaldehyde technical grade,usp/ep/jp grade.


Related News: The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. 2-pyridin-4-ylbenzaldehyde manufacturer The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application. 2-pyridin-4-ylbenzaldehyde supplier Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. 2-pyridin-4-ylbenzaldehyde vendor Toxic forever chemicals have no place in personal care products,” Scott Faber, EWG’s senior vice president of government affairs. “PFAS have been linked to serious health problems, including cancer and harm to the reproductive and immune systems. EWG applauds Sen. Collins and Rep. Dingell for introducing the No PFAS in Cosmetics Act. 2-pyridin-4-ylbenzaldehyde factory Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process.